Literature DB >> 8876886

Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

C P Karakousis1, C M Balch, M M Urist, M M Ross, T J Smith, A A Bartolucci.   

Abstract

BACKGROUND: In the past, radical margins of excision were prescribed for cutaneous melanoma based on preconceived notions rather than on hard clinical evidence.
METHODS: In a prospective study of 742 patients with intermediate-thickness melanoma (1-4 mm), 470 patients with trunk or proximal extremity lesions were randomized into a 2- or 4-cm margin. Patients with distal extremity or head and neck lesions (n = 272) received uniformly a 2-cm margin.
RESULTS: The overall rate of local recurrence was 3.8%. This rate in the randomized portion (n = 470) was 2.1% for the 2-cm margin and 2.6% for the 4-cm margin (p = 0.72). A progressive increase in local recurrence rates was observed with thickness: 2.3% for lesions 1.0-2.0 mm, 4.2% for those 2.01-3.0 mm, and 11.7% for those 3.01-4.0 mm thick (p = 0.001). Local recurrence occurred in 1.5% of those without ulceration and in 10.6% of those with ulceration of the primary lesion (p = 0.001). The local recurrence rate was not significantly affected by the margin of resection even among the thicker or ulcerated lesions. It also was not affected significantly by the method of closure of the primary site or management of the regional nodes, or the age or gender of the patients.
CONCLUSIONS: A 2-cm margin is as effective as a 4-cm margin in local control and survival of intermediate-thickness melanomas. The local recurrence rate is significantly affected by the thickness of the primary lesion and the presence or not of ulceration.

Entities:  

Mesh:

Year:  1996        PMID: 8876886     DOI: 10.1007/bf02305762

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Cancer statistics, 1992.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1992 Jan-Feb       Impact factor: 508.702

2.  Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

Authors:  U Veronesi; N Cascinelli; J Adamus; C Balch; D Bandiera; A Barchuk; R Bufalino; P Craig; J De Marsillac; J C Durand
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

3.  Optimal size of resection margin for thin cutaneous melanoma.

Authors:  A Breslow; S D Macht
Journal:  Surg Gynecol Obstet       Date:  1977-11

4.  Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma.

Authors:  U Veronesi; N Cascinelli
Journal:  Arch Surg       Date:  1991-04

5.  Cutaneous melanoma of the head and neck.

Authors:  T R Loree; R H Spiro
Journal:  Am J Surg       Date:  1989-10       Impact factor: 2.565

6.  Management of cutaneous melanoma in the United States.

Authors:  C M Balch; C Karakousis; C Mettlin; N Natarajan; W L Donegan; C R Smart; G P Murphy
Journal:  Surg Gynecol Obstet       Date:  1984-04

7.  Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

Authors:  C M Balch; M M Urist; C P Karakousis; T J Smith; W J Temple; K Drzewiecki; W R Jewell; A A Bartolucci; M C Mihm; R Barnhill
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

  7 in total
  33 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

2.  Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.

Authors:  Travis E Grotz; Svetomir N Markovic; Lori A Erickson; William S Harmsen; Marianne Huebner; David R Farley; Barbara A Pockaj; John H Donohue; Franklin H Sim; Clive S Grant; Sanjay P Bagaria; Thomas C Shives; Charles M Balch; James W Jakub
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

3.  Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma.

Authors:  Carmelo Lucio Sturiale; Giovanni Sabatino; Alessio Albanese; Mario Balducci; Libero Lauriola; Ilaria Pennacchia; Giulio Maira
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

Review 4.  The role of radiation therapy in the management of cutaneous melanoma.

Authors:  Charlene E Kan; David B Mansur
Journal:  Melanoma Manag       Date:  2016-02-24

5.  Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins.

Authors:  Alexandra B Gonzalez; Christian L Baum; Jerry D Brewer; Christopher J Arpey; William S Harmsen; Vera J Suman; Svetomir N Markovic; James W Jakub
Journal:  J Surg Oncol       Date:  2018-08-16       Impact factor: 3.454

Review 6.  Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Philip I Haigh; L Andrew DiFronzo; David R McCready
Journal:  Can J Surg       Date:  2003-12       Impact factor: 2.089

7.  Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

Authors:  Matthew C Perez; Felipe R de Pinho; Amanda Holstein; Daniel E Oliver; Syeda M H Naqvi; Youngchul Kim; Jane L Messina; Erin Burke; Ricardo J Gonzalez; Amod A Sarnaik; C Wayne Cruse; Evan J Wuthrick; Louis B Harrison; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2018-08-02       Impact factor: 5.344

Review 8.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

9.  Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?

Authors:  Katharine A Yao; Eddy C Hsueh; Richard Essner; Leland J Foshag; Leslie A Wanek; Donald L Morton
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

10.  S-100B concentrations predict disease-free survival in stage III melanoma patients.

Authors:  S Kruijff; E Bastiaannet; A C Muller Kobold; R J van Ginkel; A J H Suurmeijer; H J Hoekstra
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.